These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 36966367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
    Preston AJ, Keenan CM, Sutherland H, Wilson PJ, Wlodarski B, Taylor AM, Williams DP, Ranganath LR, Gallagher JA, Jarvis JC.
    Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
    [Abstract] [Full Text] [Related]

  • 5. Characterizing the alkaptonuria joint and spine phenotype and assessing the effect of homogentisic acid lowering therapy in a large cohort of 87 patients.
    Ranganath LR, Khedr M, Vinjamuri S, Gallagher JA.
    J Inherit Metab Dis; 2021 May; 44(3):666-676. PubMed ID: 33452825
    [Abstract] [Full Text] [Related]

  • 6. Alkaptonuria - Past, present and future.
    Davison AS, Norman BP.
    Adv Clin Chem; 2023 May; 114():47-81. PubMed ID: 37268334
    [Abstract] [Full Text] [Related]

  • 7. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy.
    Zaib S, Rana N, Hussain N, Ogaly HA, Dera AA, Khan I.
    Molecules; 2023 Mar 14; 28(6):. PubMed ID: 36985595
    [Abstract] [Full Text] [Related]

  • 8. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R.
    Indian J Biochem Biophys; 2013 Oct 14; 50(5):339-44. PubMed ID: 24772955
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of low dose nitisinone in the management of alkaptonuria.
    Sloboda N, Wiedemann A, Merten M, Alqahtani A, Jeannesson E, Blum A, Henn-Ménétré S, Guéant JL, Renard E, Feillet F.
    Mol Genet Metab; 2019 Jul 14; 127(3):184-190. PubMed ID: 31235217
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria.
    Norman BP, Sutherland H, Wilson PJM, Rutland DA, Milan AM, Hughes AT, Davison AS, Khedr M, Jarvis JC, Gallagher JA, Bou-Gharios G, Ranganath LR.
    J Inherit Metab Dis; 2024 Jul 14; 47(4):664-673. PubMed ID: 38487984
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adequacy of nitisinone for the management of alkaptonuria.
    Abbas K, Basit J, Rehman MEU.
    Ann Med Surg (Lond); 2022 Aug 14; 80():104340. PubMed ID: 36045846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems.
    Cox TF, Ranganath L.
    J Inherit Metab Dis; 2011 Dec 14; 34(6):1153-62. PubMed ID: 21744089
    [Abstract] [Full Text] [Related]

  • 18. Patient-reported outcomes and functional assessments of patients with Alkaptonuria in a 3-year Nitisinone treatment trial.
    Spears KR, Rossignol F, Perry MB, Kayser MA, Suwannarat P, O'Brien KE, Bryant JC, Greenwood WF, Fuller S, Gahl WA, Introne WJ.
    Mol Genet Metab; 2024 Dec 14; 143(1-2):108562. PubMed ID: 39121793
    [Abstract] [Full Text] [Related]

  • 19. Use of nitisinone in patients with alkaptonuria.
    Suwannarat P, O'Brien K, Perry MB, Sebring N, Bernardini I, Kaiser-Kupfer MI, Rubin BI, Tsilou E, Gerber LH, Gahl WA.
    Metabolism; 2005 Jun 14; 54(6):719-28. PubMed ID: 15931605
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.